Injection site hypoaesthesia: Which Medications Cause It? (1,273 Reports Across 53 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Injection site hypoaesthesia has been reported as an adverse event with 53 different drugs in the FDA's FAERS database, with 1,273 total reports. The drugs most commonly associated with Injection site hypoaesthesia are DUPILUMAB, ADALIMUMAB, and ETANERCEPT.
1,273
Total Reports
53
Drugs Involved
0
Deaths
103
Hospitalizations
47.4 yrs
Average Patient Age
73.4% / 26.6%
Female / Male
Which Drugs Cause Injection site hypoaesthesia Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| DUPILUMAB | 94 | 0.0% | 0 | 5 | 0 |
| ADALIMUMAB | 84 | 0.0% | 0 | 9 | 0 |
| ETANERCEPT | 73 | 0.0% | 0 | 2 | 0 |
| EPINEPHRINE | 62 | 0.4% | 0 | 2 | 1 |
| HYDROXYPROGESTERONE CAPROATE | 60 | 0.3% | 0 | 3 | 0 |
| TIRZEPATIDE | 58 | 0.1% | 0 | 0 | 0 |
| EVOLOCUMAB | 56 | 0.0% | 0 | 2 | 1 |
| DEOXYCHOLIC ACID | 52 | 2.3% | 0 | 0 | 0 |
| ONABOTULINUMTOXINA | 47 | 0.1% | 0 | 1 | 0 |
| GLATIRAMER | 39 | 0.1% | 0 | 3 | 0 |
| INTERFERON BETA-1A | 39 | 0.1% | 0 | 7 | 0 |
| OMALIZUMAB | 36 | 0.1% | 0 | 16 | 2 |
| DULAGLUTIDE | 34 | 0.1% | 0 | 0 | 0 |
| ALIROCUMAB | 25 | 0.1% | 0 | 0 | 0 |
| ERENUMAB-AOOE | 20 | 0.0% | 0 | 1 | 0 |
| OCTREOTIDE | 20 | 0.1% | 0 | 10 | 4 |
| SECUKINUMAB | 20 | 0.0% | 0 | 1 | 1 |
| NALTREXONE | 18 | 0.1% | 0 | 1 | 0 |
| OFATUMUMAB | 18 | 0.1% | 0 | 1 | 0 |
| INTERFERON BETA-1B | 16 | 0.1% | 0 | 3 | 0 |